RHEP 10% Owner Bradley L. Radoff Buys and Sells Shares

What Happened Bradley L. Radoff (reported jointly with The Radoff Family Foundation; a >10% holder) made multiple open-market/private purchases of Regional Health Properties (RHEP) stock in April 2026 and later sold a small amount in June 2026. Combined purchases: 16,020 units (including 1,600 derivative units) across trades on April 13–29 and April 14–15 (derivative buys) for about $22,673 total. Sales: 5,100 shares sold on June 5 and June 15 for about $5,856. Net result: +10,920 shares and a net cash outflow of roughly $16,817 (purchases minus sales).

Key Details

• Purchase dates/prices: Apr 13 (6,300 @ $1.29; 100 @ $1.21), Apr 14 (3,511 @ $1.30; 600 derivative @ $2.13), Apr 15 (1,000 derivative @ $2.20), Apr 22 (2,000 @ $1.43; 500 @ $1.40), Apr 27 (1,000 @ $1.40), Apr 29 (1,009 @ $1.42).
• Sales: Jun 5 — 5,000 @ $1.15; Jun 15 — 100 @ $1.06.
• Shares owned after transactions: Not specified in the provided excerpt; the Reporting Persons are part of a group that beneficially owns more than 10% of RHEP (see footnote).
• Footnotes: Joint filing by Bradley L. Radoff and The Radoff Family Foundation (F1). Radoff Foundation securities are owned directly by the foundation; Mr. Radoff, as a director, disclaims pecuniary interest in those shares (F2). The derivative securities relate to Series D Preferred Stock, which is convertible into common stock at a formulaic ratio and is subject to a 19.99% beneficial ownership cap; Series D has no expiration (F3).
• Timeliness: Form 4 filed Aug 4, 2026 reporting transactions from Apr–Jun 2026; this appears late relative to the typical 2-business-day reporting requirement.

Context Two purchases are labeled as derivative acquisitions — per the filing these relate to Series D preferred shares that can convert into common stock under specified terms and are subject to a 19.99% conversion ownership cap. Because the filing is by a >10% owner and a related foundation (not an ordinary employee trading disclosure), interpret these as institutional/owner activity rather than routine executive compensation transactions. Purchases generally carry more informational weight for retail investors than small, routine sales, but this summary is factual and does not speculate on motives.